TABLE 1.
Summary descriptives for all patients. Qualitative variables are shown in absolute frequencies (percentages); quantitative variables shown as median [minimum; maximum].
| n | |
|---|---|
| Type of patient: 67 | |
| 1st CR | 44 (65.7%) |
| Primary refractory | 23 (34.3%) |
| Gender: 67 | |
| Female | 29 (43.3%) |
| Male | 38 (56.7%) |
| Age at diagnosis (years): 67 | 3.6 [1.2;13.5] |
| Stage: 67 | |
| 3 | 1 (1.5%) |
| 4 | 66 (98.5%) |
| MYCN: 66 | |
| Amplified | 12 (18.2%) |
| Not amplified | 54 (81.8%) |
| Chemo cycles: 67 | |
| 5 or less | 14 (20.9%) |
| More than 5 | 53 (79.1%) |
| Previous ASCT: 67 | |
| No | 54 (80.6%) |
| Yes | 13 (19.4%) |
| Previous RT: 67 | |
| No | 27 (40.3%) |
| Yes | 40 (59.7%) |
| MRD: 67 | |
| No | 51 (76.1%) |
| Yes | 16 (23.9%) |
| Dinutuximab: 67 | |
| No | 46 (68.7%) |
| Yes | 21 (31.3%) |